Correlation Between Zentalis Pharmaceuticals and Bright Minds

Can any of the company-specific risk be diversified away by investing in both Zentalis Pharmaceuticals and Bright Minds at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zentalis Pharmaceuticals and Bright Minds into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Zentalis Pharmaceuticals Llc and Bright Minds Biosciences, you can compare the effects of market volatilities on Zentalis Pharmaceuticals and Bright Minds and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zentalis Pharmaceuticals with a short position of Bright Minds. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zentalis Pharmaceuticals and Bright Minds.

Diversification Opportunities for Zentalis Pharmaceuticals and Bright Minds

-0.17

Correlation Coefficient

Zentalis Pharmaceuticals  Bright Minds

Good diversification

The 3 months correlation between Zentalis and Bright is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Zentalis Pharmaceuticals Llc and Bright Minds Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bright Minds Biosciences and Zentalis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zentalis Pharmaceuticals Llc are associated (or correlated) with Bright Minds. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bright Minds Biosciences has no effect on the direction of Zentalis Pharmaceuticals i.e., Zentalis Pharmaceuticals and Bright Minds go up and down completely randomly.

Pair Corralation between Zentalis Pharmaceuticals and Bright Minds

Given the investment horizon of 90 days Zentalis Pharmaceuticals Llc is expected to under-perform the Bright Minds. But the stock apears to be less risky and, when comparing its historical volatility, Zentalis Pharmaceuticals Llc is 21.6 times less risky than Bright Minds. The stock trades about -0.02 of its potential returns per unit of risk. The Bright Minds Biosciences is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  124.00  in Bright Minds Biosciences on September 16, 2024 and sell it today you would earn a total of  3,976  from holding Bright Minds Biosciences or generate 3206.45% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Zentalis Pharmaceuticals Llc  vs.  Bright Minds Biosciences

Zentalis Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Zentalis Pharmaceuticals Llc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Bright Minds Biosciences

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Bright Minds Biosciences are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly inconsistent basic indicators, Bright Minds reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Zentalis Pharmaceuticals and Bright Minds

The main advantage of trading using opposite Zentalis Pharmaceuticals and Bright Minds positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zentalis Pharmaceuticals position performs unexpectedly, Bright Minds can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bright Minds will offset losses from the drop in Bright Minds' long position.

The idea behind Zentalis Pharmaceuticals Llc and Bright Minds Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.